This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings: Archive
Q2 Earnings Season Arrives: Can Results Match Upbeat Expectations?
by Sheraz Mian
The big banks dominate this week's reporting docket, though several notable companies from other sectors will also report, including Netflix, Johnson & Johnson, and others. With the outlook trending consistently higher, will companies be able to live up to expectations?
BACPositive Net Change WFCPositive Net Change JPMPositive Net Change CPositive Net Change
earnings finance tech-stocks
Apple vs. Broadcom: Is Either Stock a Buy After Their $30 Billion Chip Partnership?
by Shaun Pruitt
Apple and Broadcom have expanded their long-standing partnership with a multiyear agreement expected to exceed $30 billion.
AAPLNegative Net Change AVGONegative Net Change NVDAPositive Net Change
artificial-intelligence computers earnings electronics investing large-cap semiconductor tech-stocks
The AI Sell-Off That Isn't About AI
by David Bartosiak
When expectations get ahead of reality, stocks tend to sell off. But that doesn't mean that the story is over. Far from it. Dave Bartosiak will help you gain the discipline to navigate volatility and maximize the extraordinary potential of AI.
AAPLNegative Net Change AVGONegative Net Change NVDAPositive Net Change
artificial-intelligence earnings
Why Silicon Motion (SIMO) Might be Well Poised for a Surge
by Zacks Equity Research
Silicon Motion (SIMO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
SIMOPositive Net Change
earnings earnings-estimates earnings-estimates-revisions price-performance stock-performance zacks-consensus-estimate zacks-rank
Why RTX (RTX) Could Beat Earnings Estimates Again
by Zacks Equity Research
RTX (RTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RTXPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Pfizer (PFE) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PFENegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will Amphenol (APH) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Amphenol (APH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
APHNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Northrop Grumman (NOC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Northrop Grumman (NOC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NOCPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Will General Dynamics (GD) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
General Dynamics (GD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
GDPositive Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate
Why Royalty Pharma (RPRX) Could Beat Earnings Estimates Again
by Zacks Equity Research
Royalty Pharma (RPRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RPRXNegative Net Change
earnings earnings-beat earnings-esp earnings-estimates earnings-streak zacks-consensus-estimate